Administration of panobinostat is associated with increased IL-17A mRNA in the intestinal epithelium of HIV-1 patients
Main Authors: | A. Bjerg Christensen, A. Dige, J. Randel Nyengaard, J. Agnholt, P.W. Denton |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-12-01
|
Series: | Journal of Virus Eradication |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2055664020313972 |
Similar Items
-
Administration of Panobinostat Is Associated with Increased IL-17A mRNA in the Intestinal Epithelium of HIV-1 Patients
by: Ane Bjerg Christensen, et al.
Published: (2015-01-01) -
Expression of mRNA IL-1β, IL-17А and IL-10 of oral epithelium in diabetic children
by: A.V. Kotelban, et al.
Published: (2017-02-01) -
Effects of Anti-TNFα Treatment on Mucosal Expression of IL-17A, IL-21, and IL-22 and Cytokine-Producing T Cell Subsets in Crohn’s Disease
by: Anders Dige, et al.
Published: (2018-01-01) -
Efficacy of Panobinostat for the Treatment of Multiple Myeloma
by: Evangelos Eleutherakis-Papaiakovou, et al.
Published: (2020-01-01) -
Peripheral blood CD4+ T cells and intestinal lamina propria mononuclear cells contribute to viremia following an analytical treatment interruption: a follow-up analysis of the panobinostat trial
by: K. Barton, et al.
Published: (2015-12-01)